XML 155 R6.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Consolidated Statements of Changes in Equity - USD ($)
shares in Millions, $ in Millions
Total
Ordinary Shares [Member]
MCPS [Member]
 [1]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Treasury Shares [Member]
Total Teva Shareholders' Equity [Member]
Non-controlling Interests [Member]
Beginning balance at Dec. 31, 2016 $ 34,993 $ 54 $ 3,620 $ 23,409 $ 13,607 $ (3,159) $ (4,194) $ 33,337 $ 1,656
Beginning balance, shares at Dec. 31, 2016   1,123              
Comprehensive income (loss) (15,080)       (16,265) 1,306   (14,959) (121)
Exercise of options by employees and vested RSUs, value [2] [2]   (45)     45 [2]  
Exercise of options by employees and vested RSUs, shares   1              
Stock-based compensation expense 133     133       133  
Dividends to ordinary shareholders (901)       (901)     (901)  
Dividends to preferred shareholders (249)   11 (11) (249)     (249)  
Transactions with non-controlling interests (111)               (111)
Other (40)     (7) 5     (2) (38)
Ending balance at Dec. 31, 2017 18,745 $ 54 3,631 23,479 (3,803) (1,853) (4,149) 17,359 1,386
Ending balance, shares at Dec. 31, 2017   1,124              
Cumulative effect of new accounting standard [3]         (5) 5      
Comprehensive income (loss) (3,057)       (2,150) (611)   (2,761) (296)
Issuance of shares, value [4] (52) $ 2 (3,880) 3,826       (52)  
Issuance of shares, shares [4]   72              
Issuance of Treasury Shares 4 [2]   (3)     7 4  
Stock-based compensation expense 155     155       155  
Dividends to preferred shareholders     $ 249 (249)          
Transactions with non-controlling interests (1)     2       2 (3)
Ending balance at Dec. 31, 2018 15,794 $ 56   27,210 (5,958) (2,459) (4,142) 14,707 1,087
Ending balance, shares at Dec. 31, 2018   1,196              
Comprehensive income (loss) (840)       (999) 147   (852) 12
Issuance of shares, value [2]              
Issuance of shares, shares   2              
Issuance of Treasury Shares 6 [2]   (8)     14 6  
Stock-based compensation expense 119     119       119  
Transactions with non-controlling interests (8)               (8)
Other (8)     (8)       (8)  
Ending balance at Dec. 31, 2019 $ 15,063 $ 56   $ 27,312 $ (6,956) $ (2,312) $ (4,128) $ 13,972 $ 1,091
Ending balance, shares at Dec. 31, 2019   1,198              
[1] Mandatory convertible preferred shares.
[2] Represents an amount less than 0.5 million.
[3] Following the adoption of ASU 2016-01, the Company recorded a $ 5 million opening balance reclassification from accumulated other comprehensive income to retained earnings.
[4] Mainly MCPS conversion